Post-streptococcal glomerulonephritis primary prevention: Difference between revisions
Jump to navigation
Jump to search
| Line 9: | Line 9: | ||
==Primary Prevention== | ==Primary Prevention== | ||
*Effective measures for the primary prevention of post-streptococcal glomerulonephritis include: | *Effective measures for the primary prevention of post-streptococcal glomerulonephritis include: | ||
**Spread of [[group A streptococcal infection]] should be reduced by following methods:<ref name="urlGroup A Strep | Post-Streptococcal Glomerulonephritis | For Clinicians | GAS | CDC">{{cite web |url=https://www.cdc.gov/groupastrep/diseases-hcp/post-streptococcal.html |title=Group A Strep | Post-Streptococcal Glomerulonephritis | For Clinicians | GAS | CDC |format= |work= |accessdate=}}</ref><ref name="pmid10223684">{{cite journal| author=Johnston F, Carapetis J, Patel MS, Wallace T, Spillane P| title=Evaluating the use of penicillin to control outbreaks of acute poststreptococcal glomerulonephritis. | journal=Pediatr Infect Dis J | year= 1999 | volume= 18 | issue= 4 | pages= 327-32 | pmid=10223684 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10223684 }}</ref><ref name="pmid6110037">{{cite journal| author=Rodríguez-Iturbe B, Rubio L, García R| title=Attack rate of poststreptococcal nephritis in families. A prospective study. | journal=Lancet | year= 1981 | volume= 1 | issue= 8217 | pages= 401-3 | pmid=6110037 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6110037 }}</ref> | **Spread of [[group A streptococcal infection]] should be reduced by following methods:<ref name="urlGroup A Strep | Post-Streptococcal Glomerulonephritis | For Clinicians | GAS | CDC">{{cite web |url=https://www.cdc.gov/groupastrep/diseases-hcp/post-streptococcal.html |title=Group A Strep | Post-Streptococcal Glomerulonephritis | For Clinicians | GAS | CDC |format= |work= |accessdate=}}</ref><ref name="pmid10223684">{{cite journal| author=Johnston F, Carapetis J, Patel MS, Wallace T, Spillane P| title=Evaluating the use of penicillin to control outbreaks of acute poststreptococcal glomerulonephritis. | journal=Pediatr Infect Dis J | year= 1999 | volume= 18 | issue= 4 | pages= 327-32 | pmid=10223684 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10223684 }}</ref><ref name="pmid6110037">{{cite journal| author=Rodríguez-Iturbe B, Rubio L, García R| title=Attack rate of poststreptococcal nephritis in families. A prospective study. | journal=Lancet | year= 1981 | volume= 1 | issue= 8217 | pages= 401-3 | pmid=6110037 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6110037 }}</ref><ref name="pmid18667731">{{cite journal| author=Rodriguez-Iturbe B, Musser JM| title=The current state of poststreptococcal glomerulonephritis. | journal=J Am Soc Nephrol | year= 2008 | volume= 19 | issue= 10 | pages= 1855-64 | pmid=18667731 | doi=10.1681/ASN.2008010092 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18667731 }}</ref> | ||
***Improving [[hand]] hygiene | ***Improving [[hand]] hygiene | ||
***Better housing | ***Better housing | ||
Latest revision as of 16:53, 12 June 2018
|
Post-streptococcal glomerulonephritis Microchapters |
|
Differentiating Post-streptococcal glomerulonephritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Post-streptococcal glomerulonephritis primary prevention On the Web |
|
American Roentgen Ray Society Images of Post-streptococcal glomerulonephritis primary prevention |
|
FDA on Post-streptococcal glomerulonephritis primary prevention |
|
CDC on Post-streptococcal glomerulonephritis primary prevention |
|
Post-streptococcal glomerulonephritis primary prevention in the news |
|
Blogs on Post-streptococcal glomerulonephritis primary prevention |
|
Directions to Hospitals Treating Post-streptococcal glomerulonephritis |
|
Risk calculators and risk factors for Post-streptococcal glomerulonephritis primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]
Overview
Effective measures for the primary prevention of post-streptococcal glomerulonephritis include improving hand hygiene, better housing, prevent overcrowding, treatment of an infected patient within 24 hours with antibiotics and prevent close contact. A 26-valent vaccine is recommended for children to prevent post-streptococcal glomerulonephritis.
Primary Prevention
- Effective measures for the primary prevention of post-streptococcal glomerulonephritis include:
- Spread of group A streptococcal infection should be reduced by following methods:[1][2][3][4]
- Improving hand hygiene
- Better housing
- Prevent overcrowding
- Treatment of infected patient within 24 hours with antibiotics
- Prevent close contact
- Spread of group A streptococcal infection should be reduced by following methods:[1][2][3][4]
- A 26-valent vaccine is recommended for children to prevent post-streptococcal glomerulonephritis.[5]
References
- ↑ "Group A Strep | Post-Streptococcal Glomerulonephritis | For Clinicians | GAS | CDC".
- ↑ Johnston F, Carapetis J, Patel MS, Wallace T, Spillane P (1999). "Evaluating the use of penicillin to control outbreaks of acute poststreptococcal glomerulonephritis". Pediatr Infect Dis J. 18 (4): 327–32. PMID 10223684.
- ↑ Rodríguez-Iturbe B, Rubio L, García R (1981). "Attack rate of poststreptococcal nephritis in families. A prospective study". Lancet. 1 (8217): 401–3. PMID 6110037.
- ↑ Rodriguez-Iturbe B, Musser JM (2008). "The current state of poststreptococcal glomerulonephritis". J Am Soc Nephrol. 19 (10): 1855–64. doi:10.1681/ASN.2008010092. PMID 18667731.
- ↑ Dale JB, Penfound T, Chiang EY, Long V, Shulman ST, Beall B (July 2005). "Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes". Clin. Diagn. Lab. Immunol. 12 (7): 833–6. doi:10.1128/CDLI.12.7.833-836.2005. PMC 1182208. PMID 16002631.